Market Tracker

10/20 5:16pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

4.08
Delayed Data
As of Oct 20
 -0.05 / -1.21%
Today’s Change
1.97
Today|||52-Week Range
5.78
+88.99%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close4.13
Today’s open4.08
Day’s range3.99 - 4.15
Volume108,722
Average volume (3 months)270,684
Market cap$186.2M
Dividend yield--
Data as of 4:00pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+55.10%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+28.97%
P/E ratioNM
Price/Sales2.77
Price/Book3.39

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp-0.30-6.67%
MDWDMediwound Ltd-0.10-1.96%
SRNESorrento Therapeutic...+0.30+12.00%
TRVNTrevena Inc+0.10+6.02%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateDecember 12, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$57.6M
Annual profit (last year)-$28.2M
Net profit margin-48.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts